Exclusive Agreements between Federal Agencies and Bristol-Myers Squibb Co. for Drug Development:
Is the Public Interest Protected? Hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business,...

by United States